Tetyana V Masyuk

US Patent:

20090170754, Jul 2, 2009

Filed:

May 1, 2006

Appl. No.:

11/915107

Inventors:

Nicholas F. Larusso - Rochester MN, US
Tetyana V. Masyuk - Rochester MN, US
Melissa Muff-Luett - Minneapolis MN, US

Assignee:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN

International Classification:

A61K 38/12
C12N 5/06
A61K 38/08
A61K 38/22

US Classification:

514 11, 435375, 514 16, 514 12

Abstract:

This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP inhibitors to treat liver conditions are provided.

US Patent:

20120277153, Nov 1, 2012

Filed:

Jun 26, 2012

Appl. No.:

13/533257

Inventors:

Nicholas F. LaRusso - Rochester MN, US
Tetyana V. Masyuk - Rochester MN, US
Melissa Muff-Luett - Minneapolis MN, US

International Classification:

A61K 38/31
C12N 5/071
C12Q 1/18
A61P 1/16

US Classification:

514 111, 435375, 435370, 435 32

Abstract:

This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP inhibitors to treat liver conditions are provided.

US Patent:

20130178522, Jul 11, 2013

Filed:

Jul 19, 2011

Appl. No.:

13/811234

Inventors:

James M. Jamison - Stow OH, US
Deborah R. Neal - Uniontown OH, US
Mark William Kovacik - Mogadore OH, US
Michael John Askew - Strongsville OH, US
Richard Albert Mostardi - Ravenna OH, US
Karen M. McGuire - Akron OH, US
Thomas M. Miller - El Cajon CA, US
Tetyana V. Masyuk - Rochester MN, US
Nicholas F. LaRusso - Rochester MN, US

International Classification:

A61K 31/341
A61K 31/185
A61K 31/255
A61K 31/122

US Classification:

514474

Abstract:

Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NFKB-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K.

US Patent:

20170157205, Jun 8, 2017

Filed:

Nov 30, 2016

Appl. No.:

15/365695

Inventors:

- Rochester MN, US
Tetyana V. Masyuk - Rochester MN, US
Melissa Muff-Luett - North Liberty IA, US

International Classification:

A61K 38/12
A61K 38/04

Abstract:

This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP inhibitors to treat liver conditions are provided.

US Patent:

20160089417, Mar 31, 2016

Filed:

Oct 27, 2015

Appl. No.:

14/924032

Inventors:

- Rochester MN, US
Tetyana V. Masyuk - Rochester MN, US
Melissa Muff-Luett - North Liberty IA, US

International Classification:

A61K 38/12

Abstract:

This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP inhibitors to treat liver conditions are provided.

US Patent:

20150258179, Sep 17, 2015

Filed:

Mar 23, 2015

Appl. No.:

14/665559

Inventors:

- Rochester MN, US
Tetyana V. Masyuk - Rochester MN, US
Melissa Muff-Luett - North Liberty IA, US

International Classification:

A61K 38/31

Abstract:

This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP inhibitors to treat liver conditions are provided.